These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 6413885

  • 1. Evidence for the involvement of central dopaminergic receptors in the acute and chronic effects induced by barbiturates.
    Feigenbaum JJ, Yanai J.
    Neuropsychobiology; 1983; 9(2-3):83-7. PubMed ID: 6413885
    [Abstract] [Full Text] [Related]

  • 2. The role of dopaminergic mechanisms in mediating the central behavioral effects of morphine in rodents.
    Feigenbaum J, Yanai J.
    Neuropsychobiology; 1984; 11(2):98-105. PubMed ID: 6090975
    [Abstract] [Full Text] [Related]

  • 3. Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouse.
    Feigenbaum JJ, Yanai J.
    Neuropharmacology; 1985 Aug; 24(8):735-41. PubMed ID: 3939327
    [Abstract] [Full Text] [Related]

  • 4. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic modulation of footshock induced aggression in paired rats.
    Datla KP, Sen AP, Bhattacharya SK.
    Indian J Exp Biol; 1992 Jul; 30(7):587-91. PubMed ID: 1360943
    [Abstract] [Full Text] [Related]

  • 6. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ, Arbilla S, Galzin AM, Langer SZ.
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [Abstract] [Full Text] [Related]

  • 7. 5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade.
    Saller CF, Czupryna MJ, Salama AI.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1162-70. PubMed ID: 2141636
    [Abstract] [Full Text] [Related]

  • 8. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG, Vizi ES.
    Pol J Pharmacol Pharm; 1985 Jun; 37(3):383-96. PubMed ID: 2866504
    [Abstract] [Full Text] [Related]

  • 9. Modification of dopamine receptor-mediated processes after chronic ethanol intoxication: a possible mechanism.
    Hoffman PL, Tabakoff B.
    Adv Exp Med Biol; 1980 Jun; 126():21-42. PubMed ID: 7190764
    [Abstract] [Full Text] [Related]

  • 10. Pimozide: delayed onset of action at rat striatal pre- and postsynaptic dopamine receptors.
    McMillen BA, German DC, Sanghere MK, Warnack W, Shore PA.
    J Pharmacol Exp Ther; 1980 Oct; 215(1):150-5. PubMed ID: 6109013
    [Abstract] [Full Text] [Related]

  • 11. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
    Ferretti C, Benfenati F, Cimino M, Vantini G, Lipartiti M, Muccioli G, di Carlo R, Algeri S.
    Med Biol; 1983 Oct; 61(6):331-6. PubMed ID: 6676604
    [Abstract] [Full Text] [Related]

  • 12. The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments.
    Herrera-Marschitz M, Ungerstedt U.
    Acta Physiol Scand; 1987 Mar; 129(3):371-80. PubMed ID: 3033996
    [Abstract] [Full Text] [Related]

  • 13. Comparison of chlorpromazine, haloperidol and pimozide in the treatment of phencyclidine psychosis: DA-2 receptor specificity.
    Giannini AJ, Nageotte C, Loiselle RH, Malone DA, Price WA.
    J Toxicol Clin Toxicol; 1987 Mar; 22(6):573-9. PubMed ID: 6535849
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M.
    J Neural Transm Suppl; 1986 Mar; 22():33-45. PubMed ID: 2946813
    [Abstract] [Full Text] [Related]

  • 15. Classification of neuroleptics: implications for tardive dyskinesia.
    Christensen AV.
    Pol J Pharmacol Pharm; 1985 Mar; 37(3):295-309. PubMed ID: 2866499
    [Abstract] [Full Text] [Related]

  • 16. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A, Billiras R, Cistarelli L, Millan MJ.
    J Neurosci Methods; 2004 Dec 30; 140(1-2):141-52. PubMed ID: 15589344
    [Abstract] [Full Text] [Related]

  • 17. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX, Hoffmann IS, James MK, Niedzwiecki DM.
    J Pharmacol Exp Ther; 1983 Sep 30; 226(3):680-5. PubMed ID: 6887008
    [Abstract] [Full Text] [Related]

  • 18. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 30; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 19. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A, Ceresoli G, Mandelli V, Parenti M.
    J Pharmacol Exp Ther; 1990 Jun 30; 253(3):950-6. PubMed ID: 2162953
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of dopamine antagonism by morphine in rodents.
    Feigenbaum JJ, Fishman RH, Yanai J.
    Subst Alcohol Actions Misuse; 1982 Jun 30; 3(6):307-24. PubMed ID: 6764309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.